Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 582

    1.

    Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial.

    Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, Alvarez MG, Postan M, Armenti A.

    Ann Intern Med. 2006 May 16;144(10):724-34.PMID: 16702588 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. Long-term outcomes of treating nonacute Chagas disease with benznidazole.

    [No authors listed]

    Ann Intern Med. 2006 May 16;144(10):I32. No abstract available. PMID: 16702585 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up.

    Viotti R, Vigliano C, Armenti H, Segura E.

    Am Heart J. 1994 Jan;127(1):151-62.PMID: 8273735 [PubMed - indexed for MEDLINE]Related articles

    4.

    Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection.

    de Andrade AL, Zicker F, de Oliveira RM, Almeida Silva S, Luquetti A, Travassos LR, Almeida IC, de Andrade SS, de Andrade JG, Martelli CM.

    Lancet. 1996 Nov 23;348(9039):1407-13.PMID: 8937280 [PubMed - indexed for MEDLINE]Related articles

    5.

    Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.

    Garcia S, Ramos CO, Senra JF, Vilas-Boas F, Rodrigues MM, Campos-de-Carvalho AC, Ribeiro-Dos-Santos R, Soares MB.

    Antimicrob Agents Chemother. 2005 Apr;49(4):1521-8.PMID: 15793134 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).

    Marin-Neto JA, Rassi A Jr, Morillo CA, Avezum A, Connolly SJ, Sosa-Estani S, Rosas F, Yusuf S; BENEFIT Investigators.

    Am Heart J. 2008 Jul;156(1):37-43.PMID: 18585495 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Clinical predictors of chronic chagasic myocarditis progression]

    Viotti R, Vigliano C, Lococo B, Petti M, Bertocchi G, Alvarez MG, Armenti A.

    Rev Esp Cardiol. 2005 Sep;58(9):1037-44. Spanish. PMID: 16185616 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives.

    Lauria-Pires L, Braga MS, Vexenat AC, Nitz N, Simões-Barbosa A, Tinoco DL, Teixeira AR.

    Am J Trop Med Hyg. 2000 Sep-Oct;63(3-4):111-8.PMID: 11388500 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution.

    Fabbro DL, Streiger ML, Arias ED, Bizai ML, del Barco M, Amicone NA.

    Rev Soc Bras Med Trop. 2007 Jan-Feb;40(1):1-10.PMID: 17486245 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Treatment of experimental chronic chagas disease with trifluralin.

    Zaidenberg A, Luong T, Lirussi D, Bleiz J, Del Buono MB, Quijano G, Drut R, Kozubsky L, Marron A, Buschiazzo H.

    Basic Clin Pharmacol Toxicol. 2006 Apr;98(4):351-6.PMID: 16623857 [PubMed - indexed for MEDLINE]Related articles

    11.

    Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy.

    Bustamante JM, Presti MS, Rivarola HW, Fernández AR, Enders JE, Fretes RE, Paglini-Oliva P.

    Int J Antimicrob Agents. 2007 Jun;29(6):733-7. Epub 2007 Mar 28.PMID: 17395432 [PubMed - indexed for MEDLINE]Related articles

    12.

    Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment.

    Pereira-Chioccola VL, Fragata-Filho AA, Levy AM, Rodrigues MM, Schenkman S.

    Clin Diagn Lab Immunol. 2003 Sep;10(5):826-30.PMID: 12965912 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction.

    Basquiera AL, Sembaj A, Aguerri AM, Omelianiuk M, Guzmán S, Moreno Barral J, Caeiro TF, Madoery RJ, Salomone OA.

    Heart. 2003 Oct;89(10):1186-90.PMID: 12975414 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.

    Bocchi EA, Higuchi ML, Vieira ML, Stolf N, Bellotti G, Fiorelli A, Uip D, Jatene A, Pileggi F.

    J Heart Lung Transplant. 1998 Apr;17(4):399-405.PMID: 9588585 [PubMed - indexed for MEDLINE]Related articles

    15.

    Urban outbreak of acute Chagas disease in Amazon region of Brazil: four-year follow-up after treatment with benznidazole.

    Pinto AY, Ferreira AG Jr, Valente Vda C, Harada GS, Valente SA.

    Rev Panam Salud Publica. 2009 Jan;25(1):77-83.PMID: 19341528 [PubMed - indexed for MEDLINE]Related articles

    16.

    Long term evaluation of etiological treatment of chagas disease with benznidazole.

    Cancado JR.

    Rev Inst Med Trop Sao Paulo. 2002 Jan-Feb;44(1):29-37.PMID: 11896410 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Chagas' disease: lymphoma growth in rabbits treated with Benznidazole.

    Teixeira AR, Córdoba JC, Souto Maior I, Solórzano E.

    Am J Trop Med Hyg. 1990 Aug;43(2):146-58.PMID: 2117856 [PubMed - indexed for MEDLINE]Related articles

    18.

    Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease.

    Corrales M, Cardozo R, Segura MA, Urbina JA, Basombrío MA.

    Antimicrob Agents Chemother. 2005 Apr;49(4):1556-60.PMID: 15793138 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease.

    Sosa Estani S, Segura EL, Ruiz AM, Velazquez E, Porcel BM, Yampotis C.

    Am J Trop Med Hyg. 1998 Oct;59(4):526-9.PMID: 9790423 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.

    Viotti R, Vigliano C, Lococo B, Alvarez MG, Petti M, Bertocchi G, Armenti A.

    Expert Rev Anti Infect Ther. 2009 Mar;7(2):157-63. Review.PMID: 19254164 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data